Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

نتائج البحث

Display Settings
النتائج لكل صفحة: 10
Sort By: Relevance
Filter
  • 1-10 ل  3,176 نتائج ل ""Bone Density Conservation Agents""

فلترة النتائج

إعادة تعيين خيارات الفبترة
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Change in body temperature, not acute-phase reaction, predict anti-Osteoporosis efficacy after the first administration of Zoledronic acid: a prospective observational cohort study.

  • Authors : Du Y; Department of Osteoporosis and Bone Disease, Research Section of Geriatric Metabolic Bone Disease, Huadong Hospital Affiliated to Fudan University, Shanghai Geriatric Institute, Shanghai, China.; Research Section of Geriatric Metabolic Bone Disease, Shanghai Geriatric Institute, Shanghai, China.

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/administration & dosage ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: BMC musculoskeletal disorders [BMC Musculoskelet Disord] 2024 Sep 02; Vol. 25 (1), pp. 694. Date of Electronic Publication: 2024 Sep 02.Publisher: BioMed Central Country of Publication: England NLM ID: 100968565 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2474

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate.

  • Authors : Suwan A; Division of Gender, Sexual, and Climacteric Medicine, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Center of Excellence in Transgender Health (CETH), Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.

Subjects: Risedronic Acid*/Risedronic Acid*/Risedronic Acid*/therapeutic use ; Bone Density*/Bone Density*/Bone Density*/drug effects ; Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy

  • Source: BMC women's health [BMC Womens Health] 2024 Oct 26; Vol. 24 (1), pp. 572. Date of Electronic Publication: 2024 Oct 26.Publisher: BioMed Central Country of Publication: England NLM ID: 101088690 Publication Model: Electronic Cited Medium: Internet ISSN: 1472-6874

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Comparing the Efficacy of Antiosteoporotic Drugs in Preventing Periprosthetic Bone Loss Following Total Hip Arthroplasty: A Systematic Review and Bayesian Network Meta-Analysis.

  • Authors : Tang Y; The First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Zhejiang, China.; Jin Z

Subjects: Arthroplasty, Replacement, Hip*/Arthroplasty, Replacement, Hip*/Arthroplasty, Replacement, Hip*/adverse effects ; Bayes Theorem* ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use

  • Source: Orthopaedic surgery [Orthop Surg] 2024 Oct; Vol. 16 (10), pp. 2344-2354. Date of Electronic Publication: 2024 Jul 26.Publisher: Wiley on behalf of the Chinese Orthopedic Association Country of Publication: Australia NLM ID: 101501666 Publication Model: Print-Electronic

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Efficacy and safety of minodronate in the treatment of postmenopausal osteoporosis with low back pain: a single-centre, randomized and open-label controlled trial.

  • Authors : Wang H; Department of Orthopaedics, Peking University Third Hospital, Beijing, China.; Huang J

Subjects: Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/Osteoporosis, Postmenopausal*/drug therapy ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects

  • Source: Trials [Trials] 2024 Aug 13; Vol. 25 (1), pp. 534. Date of Electronic Publication: 2024 Aug 13.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

[Expert consensus on safety management of bone-modifying agents (2024 edition)].

Subjects: Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/secondary ; Bone Neoplasms*/Bone Neoplasms*/Bone Neoplasms*/drug therapy ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects

  • Source: Zhonghua zhong liu za zhi [Chinese journal of oncology] [Zhonghua Zhong Liu Za Zhi] 2024 Jul 23; Vol. 46 (7), pp. 637-645.Publisher: Chinese Medical Association Country of Publication: China NLM ID: 7910681 Publication Model: Print Cited Medium: Print ISSN: 0253-3766

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Can zoledronic acid reduce the risk of cage subsidence after oblique lumbar interbody fusion combined with bilateral pedicle screw fixation in the elderly population? A retrospective study.

  • Authors : Jin C; Department of Orthopedics, Shaoxing People's Hospital, Zhongxing North Road, Shaoxing, Zhejiang, 312000, China.; Shang J

Subjects: Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/administration & dosage ; Zoledronic Acid*/Zoledronic Acid*/Zoledronic Acid*/therapeutic use ; Spinal Fusion*/Spinal Fusion*/Spinal Fusion*/methods

  • Source: Journal of orthopaedic surgery and research [J Orthop Surg Res] 2024 Jun 08; Vol. 19 (1), pp. 344. Date of Electronic Publication: 2024 Jun 08.Publisher: BioMed Central Country of Publication: England NLM ID: 101265112 Publication Model: Electronic Cited Medium: Internet ISSN: 1749-799X

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Podocyte Disease Following Treatment with Intravenous Ibandronate in an Older Patient.

  • Authors : Chung YR; Division of Nephrology, Department of Internal Medicine, Veterans Health Service Medical Center, Seoul, Republic of Korea.; Lee HS

Subjects: Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/adverse effects ; Bone Density Conservation Agents*/Bone Density Conservation Agents*/Bone Density Conservation Agents*/therapeutic use ; Diphosphonates*/Diphosphonates*/Diphosphonates*/adverse effects

  • Source: Annals of geriatric medicine and research [Ann Geriatr Med Res] 2024 Jun; Vol. 28 (2), pp. 228-230. Date of Electronic Publication: 2024 Feb 22.Publisher: Korean Geriatrics Society Country of Publication: Korea (South) NLM ID: 101701105 Publication Model: Print-Electronic Cited Medium: Internet

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

A Real-world Study of Denosumab For Reducing Refracture Risk after Percutaneous Vertebral Augmentation.

  • Authors : Zou J; Department of Orthopedic Surgery, First Affiliated Hospital of Soochow University, Suzhou, China.; Zhang Y

Subjects: Denosumab*/Denosumab*/Denosumab*/therapeutic use ; Spinal Fractures*/Spinal Fractures*/Spinal Fractures*/prevention & control ; Spinal Fractures*/Spinal Fractures*/Spinal Fractures*/surgery

  • Source: Orthopaedic surgery [Orthop Surg] 2024 Aug; Vol. 16 (8), pp. 1849-1860. Date of Electronic Publication: 2024 Jul 01.Publisher: Wiley on behalf of the Chinese Orthopedic Association Country of Publication: Australia NLM ID: 101501666 Publication Model: Print-Electronic

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Cumulative incidence and risk factors for medication-related osteonecrosis of the jaw during long-term prostate cancer management.

  • Authors : Tani M; Department of Urology, Osaka University Graduate School of Medicine, 2-2 Yamadaoka, Suita, Osaka, 565-0871, Japan.; Hatano K

Subjects: Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/drug therapy ; Prostatic Neoplasms*/Prostatic Neoplasms*/Prostatic Neoplasms*/pathology ; Bisphosphonate-Associated Osteonecrosis of the Jaw*/Bisphosphonate-Associated Osteonecrosis of the Jaw*/Bisphosphonate-Associated Osteonecrosis of the Jaw*/epidemiology

  • Source: Scientific reports [Sci Rep] 2024 Jun 11; Vol. 14 (1), pp. 13451. Date of Electronic Publication: 2024 Jun 11.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN:

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
Academic Journal

Pamidronate-induced irreversible symptomatic hypocalcemia in a dog with hypercalcemia after glucocorticoid withdrawal: a case report.

  • Authors : Oh YI; Department of Veterinary Internal Medicine, College of Veterinary Medicine & Institute for Veterinary Biomedical Science, Kyungpook National University, Daegu, 41566, Republic of Korea.; An JH

Subjects: Pamidronate*/Pamidronate*/Pamidronate*/therapeutic use ; Hypocalcemia*/Hypocalcemia*/Hypocalcemia*/veterinary ; Hypocalcemia*/Hypocalcemia*/Hypocalcemia*/chemically induced

  • Source: BMC veterinary research [BMC Vet Res] 2024 May 24; Vol. 20 (1), pp. 227. Date of Electronic Publication: 2024 May 24.Publisher: BioMed Central Country of Publication: England NLM ID: 101249759 Publication Model: Electronic Cited Medium: Internet ISSN: 1746-6148

تفاصيل العنوان

اقرأ على الانترنت اقرأ أكثر حفظ في قائمتي
×
  • 1-10 ل  3,176 نتائج ل ""Bone Density Conservation Agents""